Over the past two decades, drug delivery systems have undergone significant evolution, with greater scientific rigor and collaboration across multidisciplinary fields such as biology, chemistry, engineering, and pharmaceutics. At LAXAI, we work in close partnership with you to develop the most suitable formulation for your molecule, based on its physicochemical and biopharmaceutical properties, ranging from fit-for-purpose preclinical and first-in-human (FIH) dosage forms to optimized drug products for late-stage development and commercialization.
Our scientific team at LAXAI is committed to overcoming solubility, in vivo exposure, solid form, and stability challenges to help develop therapeutic compounds that are challenging to formulate from preclinical and clinical to market, tailored to your unique requirements. We work with a wide range of drug delivery systems to enhance drug bioavailability, achieve targeted delivery, and extend drug release.
Our formulation expertise is supported by our formulation development and analytical facilities, equipped with advanced technologies, including high-throughput screening, and automated formulation platforms. Our capabilities also include pre-formulation studies, drug excipient compatibility studies, and process optimization to ensure a smooth transition from laboratory to large-scale manufacturing. At LAXAI, we are committed to delivering the highest quality drug delivery solutions to advance the development of life-saving therapies.
Infrastructure and Instrumentation:
- Micronization machine
- Spray dryer
- Nanosuspension supplies